Other Insiders Active in the Same Sector
No other insider has filed at Wenbin Jiang's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BAKER BROS. ADVISORS LP - $327.32M of CELC open-market activity in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M of AVAH open-market activity in the last 12 months
- General Atlantic (ALN HLTH), L.P. - $315.49M of ALHC open-market activity in the last 12 months
- GENERAL ATLANTIC, L.P. - $315.49M of ALHC open-market activity in the last 12 months
- Fairmount Funds Management LLC - $300.01M of ORKA open-market activity in the last 12 months
- August J. Troendle - $249.99M of MEDP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Wenbin Jiang?
Wenbin Jiang is a corporate insider, tracked as PRESIDENT AND CEO, Director of Cytek Biosciences, Inc. (CTKB). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Wenbin Jiang submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Wenbin Jiang's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Wenbin Jiang and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
